Skip to main content

Table 2 Resources available to support growth hormone treatment program by the size of participating centers

From: Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

  Total (73 responses) Small centers (40 responses) Large centers (33 responses) p-value
Nutritional support for short children with pre-dialysis CKD, n (%)
 Renal dietitian
 Pediatric dietitian
 Pediatric nephrologist
50 (68.5)
9 (12.3)
15 (20.6)
20 (50.0)
7 (17.5)
13 (32.5)
30 (90.9)
1 (3.0)
2 (6.1)
0.001a
Role of endocrinology in rhGH management in CKD, n (%)
 Primary
 Initial consultation
 Challenging cases
 Rarely involved
19 (26.8)
4 (5.6)
11 (15.5)
37 (52.1)
17 (43.6)
3 (7.7)
6 (15.4)
13 (33.3)
2 (6.3)
1 (3.1)
5 (15.6)
24 (75.0)
<0.001a
Prior authorization for rhGH, n(%)
 Nurse
 Attending physician
 Other
55 (75.3)
8 (11.0)
10 (13.7)
28 (70.0)
3 (7.50)
9 (22.5)
27 (81.8)
5 (15.2)
1 (3.0)
0.04a
  1. aFisher’s exact test